JPS56139468A - 10-substituted-5-cyanmethylene-10,11-dihydro- dibenzo(a,d)cycloheptene, manufacture and medicine containing same - Google Patents
10-substituted-5-cyanmethylene-10,11-dihydro- dibenzo(a,d)cycloheptene, manufacture and medicine containing sameInfo
- Publication number
- JPS56139468A JPS56139468A JP3140881A JP3140881A JPS56139468A JP S56139468 A JPS56139468 A JP S56139468A JP 3140881 A JP3140881 A JP 3140881A JP 3140881 A JP3140881 A JP 3140881A JP S56139468 A JPS56139468 A JP S56139468A
- Authority
- JP
- Japan
- Prior art keywords
- dibenzo
- dihydro
- substituted
- cyanmethylene
- cycloheptene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19803009045 DE3009045A1 (de) | 1980-03-08 | 1980-03-08 | 10-substituierte 5-cyanmethylen-10,11-dihydro-dibenzo-(a,d) -cycloheptene |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS56139468A true JPS56139468A (en) | 1981-10-30 |
Family
ID=6096691
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3140881A Pending JPS56139468A (en) | 1980-03-08 | 1981-03-06 | 10-substituted-5-cyanmethylene-10,11-dihydro- dibenzo(a,d)cycloheptene, manufacture and medicine containing same |
Country Status (6)
Country | Link |
---|---|
US (1) | US4376773A (ja) |
EP (1) | EP0035714B1 (ja) |
JP (1) | JPS56139468A (ja) |
AT (1) | ATE10095T1 (ja) |
CA (1) | CA1163264A (ja) |
DE (2) | DE3009045A1 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4041463A1 (de) * | 1990-12-22 | 1992-06-25 | Basf Ag | 5-cyanmethylen-10-(piperazin-1-yl)-dibenzo(a,d)cycloheptene zur bekaempfung der migraene |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1620151U (de) | 1950-09-13 | 1951-02-22 | Hildegard Wolbrandt | Nachthemd. |
DE1568089A1 (de) | 1951-01-28 | 1970-01-02 | Boehringer Mannheim Gmbh | Verfahren zur Herstellung tricyclischer AEthylamin-Derivate |
FR111F (ja) * | 1964-03-27 | |||
FR90378E (ja) * | 1965-03-26 | 1968-02-14 | ||
FR1505354A (fr) * | 1966-01-25 | 1967-12-15 | Rhone Poulenc Sa | Nouveaux composés dérivés du dibenzocycloheptadiène |
NL152845B (nl) | 1966-03-11 | 1977-04-15 | Boehringer Mannheim Gmbh | Werkwijze voor het bereiden van een geneesmiddel met een psychotrope en bloedsomloopstimulerende werking, alsmede het aldus verkregen gevormde geneesmiddel, en werkwijze voor het bereiden van een geneeskrachtig omega,omega-difenylalkylaminederivaat. |
US3661909A (en) * | 1967-03-28 | 1972-05-09 | Richardson Merrell Spa | 5h-dibenzo (a,d) cyclohepten-10-yl-piperazines |
ES356805A1 (es) * | 1967-08-03 | 1970-05-01 | Hoffmann La Roche | Procedimiento para la preparacion de compuestos tricicli- cos. |
US3928356A (en) * | 1967-10-06 | 1975-12-23 | Fujisawa Pharmaceutical Co | 10-{8 4-({107 -Hydroxy alkyl)-1-piperazimyl{9 -dibenzo (h,f) oxofins and thiepins and acetyl esters thereof |
US3917602A (en) * | 1968-07-03 | 1975-11-04 | Rhone Poulenc Sa | Preparation of alkali metal amides |
BE754642A (fr) * | 1969-08-11 | 1971-02-10 | Geigy Ag J R | Derives de l'imidazolidinone et medicaments contenant de tels derives |
CA1000701A (en) | 1972-07-19 | 1976-11-30 | Leslie G. Humber | Process for preparing hexahydrobenzo (6,7) cyclohepta(1,2,3-de)isoquinolines |
DE2918778A1 (de) * | 1979-05-10 | 1980-11-20 | Basf Ag | 6-substituierte 11-alkylen-morphantridine |
-
1980
- 1980-03-08 DE DE19803009045 patent/DE3009045A1/de not_active Withdrawn
-
1981
- 1981-02-25 US US06/237,964 patent/US4376773A/en not_active Expired - Fee Related
- 1981-02-26 CA CA000371802A patent/CA1163264A/en not_active Expired
- 1981-02-27 AT AT81101422T patent/ATE10095T1/de active
- 1981-02-27 EP EP81101422A patent/EP0035714B1/de not_active Expired
- 1981-02-27 DE DE8181101422T patent/DE3166888D1/de not_active Expired
- 1981-03-06 JP JP3140881A patent/JPS56139468A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
DE3009045A1 (de) | 1981-09-24 |
EP0035714B1 (de) | 1984-10-31 |
EP0035714A3 (en) | 1982-01-20 |
EP0035714A2 (de) | 1981-09-16 |
DE3166888D1 (en) | 1984-12-06 |
ATE10095T1 (de) | 1984-11-15 |
CA1163264A (en) | 1984-03-06 |
US4376773A (en) | 1983-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IE882960L (en) | Osmotic dosage form for administering isradipine | |
AU7534087A (en) | Sustained release pharmaceutical compositions in oral dosage form | |
EP0494972A4 (en) | Effervescent dosage form and method of administering same | |
IE882391L (en) | Pad printing process | |
EP0449151A3 (en) | Material of adsorbing pyrogen | |
AU6788687A (en) | A pharmaceutical which can be administered nasally, a process for its preparation, and its use | |
ES2021579B3 (es) | Capsulas divisibles en piezas | |
DK439288D0 (da) | Laegemiddelbeholder | |
JPS56139468A (en) | 10-substituted-5-cyanmethylene-10,11-dihydro- dibenzo(a,d)cycloheptene, manufacture and medicine containing same | |
EP0222257A3 (en) | A phosphocreatine containing pharmaceutical composition and method for preparing the same | |
JPS56139446A (en) | 10-substituted-5-cyanmethylene-dibenzo (a,d)cycloheptene, manufacture and medicine containing same | |
AU2908389A (en) | Device for administering medicaments by atomization in intubated or tracheotomized patients | |
GR3019776T3 (en) | Antineoplastic medicament containing octadecyl-[2-(N-methylpiperidino)-ethyl] phosphate and synthesis thereof | |
IL79207A0 (en) | Pharmaceutical compositions containing terguide | |
GB2213062A (en) | Pharmaceutical preparation having oestrogen action | |
EP0311467A3 (en) | Use of pyrroloû3,2,1-hi¨indole derivatives in the manufacture of a medicament for the treatment of diabetes | |
DE3764233D1 (de) | Cyclopentylaether, deren herstellung und pharmazeutische formulierung. | |
ATE52090T1 (de) | Pyrazinderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen mit diesen. |